(S1 (S (S (PRN (-LRB- -LSB-) (NP (NP (NN CCR4)) (, ,) (NP (NN HTLV-1) (NN infection)) (, ,) (CC and) (NP (NN ATL) (NN oncogenesis))) (-RRB- -RSB-))) (. .)))
(S1 (S (S (NP (NP (JJ Adult) (NN T-cell) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN ATL)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NN malignancy)) (PP (IN of) (NP (JJ mature) (JJ CD4+) (NN T) (NNS cells))) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADVP (RB etiologically)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN infection)) (PP (IN of) (NP (NP (NP (JJ human) (NN T-cell) (NN leukemia) (NN virus) (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HTLV-1)) (-RRB- -RRB-))) (, ,) (NP (DT an) (JJ exogenous) (JJ human) (NN retrovirus))))))))))))) (. .)))
(S1 (S (S (ADVP (RB Previously)) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (JJ leukemic) (NNS cells)) (PP (IN of) (NP (JJS most) (NN ATL) (NNS patients)))) (VP (VBP express) (NP (NP (NN CCR4)) (, ,) (NP (NP (DT a) (NN chemokine) (NN receptor)) (VP (VBN known) (S (VP (TO to) (VP (VB be) (ADVP (RB selectively)) (VP (VBN expressed) (PP (IN by) (NP (NP (NN T) (NN cell) (NNS subsets)) (PP (JJ such) (IN as) (NP (NP (NN Th2) (NNS cells)) (, ,) (NP (JJ skin-homing) (JJ memory/effector) (NN T) (NNS cells)) (, ,) (CC and) (NP (JJ regulatory) (NN T) (NNS cells))))))))))))))))))) (. .)))
(S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN CCR4)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN ATL) (NNS cells)) (VP (VBP are) (ADVP (RB mostly)) (VP (VBN derived) (PP (IN from) (NP (NP (CD one)) (PP (IN of) (NP (DT these) (NN T) (NN cell) (NNS subsets))))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB also)) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN Tax)) (, ,) (NP (DT the) (JJ HTLV-1-encoded) (JJ potent) (JJ transcriptional) (NN activator)) (, ,)) (ADVP (RB strongly)) (VP (VBZ induces) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (CD CCL22)) (, ,) (NP (DT a) (NN CCR4) (NN ligand)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ promotes) (NP (NP (DT the) (JJ cell-dependent) (NN transmission)) (PP (IN of) (NP (NN HTLV-1))) (PP (IN from) (NP (JJ HTLV-1-infected) (NN T) (NNS cells))) (PP (TO to) (NP (JJ CCR4+) (NN target) (NN T) (NNS cells)))))))))) (PP (IN by) (S (VP (VBG inducing) (NP (JJ close) (JJ cell-to-cell) (NNS interactions))))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB also)) (VP (VBN shown) (SBAR (IN that) (S (NP (NN ATL) (NNS cells)) (ADVP (RB aberrantly)) (VP (VBP express) (NP (NP (DT the) (NN AP-1) (NN family) (NN member) (NN Fra-2)) (SBAR (WHNP (WDT which)) (S (, ,) (PP (IN by) (S (VP (VBG forming) (NP (NP (DT the) (NN heterodimer)) (PP (IN with) (NP (NN JunD))))))) (, ,) (ADVP (RB potently)) (VP (VBZ induces) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (CONJP (RB not) (RB only)) (NP (NN CCR4)) (CONJP (CC but) (RB also)) (NP (NP (DT the) (NNS genes)) (PP (JJ such) (IN as) (NP (NP (NN c-Myb)) (, ,) (NP (NN MDM2)) (CC and) (NP (NN Bcl-6))) (, ,) (NP (DT the) (JJ well-known) (NNS proto-oncogenes))))))))))))))))) (. .)))
(S1 (S (S (S (ADVP (RB Thus)) (, ,) (NP (NN Fra-2)) (VP (VBZ is) (NP (NP (DT a) (JJ novel) (NN oncogene)) (PP (IN of) (NP (NN ATL)))))) (, ,) (CC and) (S (NP (NN CCR4)) (VP (MD may) (VP (VB be) (VP (VBN regarded) (PP (IN as) (NP (NP (DT a) (JJ useful) (NN tumor) (NN marker)) (PP (IN of) (NP (NN ATL)))))))))) (. .)))
